Hsu A, Kurt H, Zayac AS, Olszewski AJ, et al. CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. Leuk Lymphoma 2021 Sep 1:1-12. doi: 10.1080/10428194.2021.1973670.
PMID: 34467833